Ali Motahharynia, Mohammadreza Ghaffarzadeh-Esfahani, Mahsa Sheikholeslami, Navid Mazrouei, Matin Irajpour, Yousof Gheisari, Hajar Sirous
Featured July 14, 2026
This analysis was generated by SciGrove. Upload your own PDFs or enter a DOI — and get the same AI breakdown on any paper.
Get startedAI-generated analysis — This is SciGrove's AI interpretation of the paper, not peer-reviewed content. Always refer to the original paper.
DrugGen-2 creates new drug molecules by understanding both the disease context and the target protein, making it better at finding effective medicines than older methods.
The system learns from existing drugs, diseases, and proteins, then uses a smart trial-and-error process to invent new drug molecules that fit a specific disease and target.
The new system creates many more unique and effective drug molecules that stick better to their targets compared to previous methods.